Disclosure Of Entity's Operating Segments [Text Block]

Transgene - Filing #881725

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
9 993 EUR
2 981 EUR
Tax expense (income)
 -  EUR
 -  EUR
Profit (loss) before tax
19 536 EUR
17 231 EUR
Profit (loss)
19 536 EUR
 -  EUR
 -  EUR
 -  EUR
 -  EUR
19 536 EUR
19 536 EUR
 -  EUR
 -  EUR
17 231 EUR
 -  EUR
 -  EUR
17 231 EUR
17 231 EUR
 -  EUR
 -  EUR
Assets
101 838 EUR
85 453 EUR
Liabilities
34 629 EUR
34 737 EUR
Cash flows from (used in) operating activities
31 943 EUR
28 742 EUR
Cash flows from (used in) investing activities
16 793 EUR
17 742 EUR
Cash flows from (used in) financing activities
15 772 EUR
14 941 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.